Clinical Trial Update: Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort [Phase 2]

View source ↗

Summary

Phase 2 trial investigating bevacizumab (Avastin/Zeribev) for efficacy and safety in patients with COVID-19 pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: COVID19 Pneumonia | Phase 2 | Status: UNKNOWN